Assessment of prognostic and reproductive outcomes of omentectomy for patients with clinically apparent early‐stage (I, II) malignant ovarian germ cell tumours: A multicentre retrospective study

This study assessed the effect of omentectomy on the prognosis and fertility in patients with clinically early‐stage (I, II) malignant ovarian germ cell tumours (MOGCT).

[1]  C. Sessa,et al.  ESGO-SIOPE guidelines for the management of adolescents and young adults with non-epithelial ovarian cancers. , 2020, The Lancet. Oncology.

[2]  Yanfang Li,et al.  Are omentectomy and lymphadenectomy necessary in patients with apparently early-stage malignant ovarian germ cell tumors? , 2019, International Journal of Gynecologic Cancer.

[3]  Yanfang Li,et al.  Is Omentectomy Mandatory Among Early Stage (I, II) Malignant Ovarian Germ Cell Tumor Patients? A Retrospective Study of 223 Cases , 2017, International Journal of Gynecologic Cancer.

[4]  A. Gadducci,et al.  The role of staging and adjuvant chemotherapy in stage I malignant ovarian germ cell tumors (MOGTs): the MITO-9 study , 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

[5]  A. L. Frazier,et al.  Conundrums in the management of malignant ovarian germ cell tumors: Toward lessening acute morbidity and late effects of treatment. , 2016, Gynecologic oncology.

[6]  H. Zhang,et al.  The role of staging surgery in the treatment of apparent early‐stage malignant ovarian germ cell tumours , 2016, The Australian & New Zealand journal of obstetrics & gynaecology.

[7]  Xiaohua Wu,et al.  Current Strategy for the Treatment of Ovarian Germ Cell Tumors: Role of Extensive Surgery , 2016, Current Treatment Options in Oncology.

[8]  PhD Jeong-Yeol Park MD,et al.  Significance of the Complete Surgical Staging of Stage I Malignant Ovarian Germ Cell Tumors , 2016, Annals of Surgical Oncology.

[9]  N. Teng,et al.  Does Omentectomy in Epithelial Ovarian Cancer Affect Survival? An Analysis of the Surveillance, Epidemiology, and End Results Database , 2015, International Journal of Gynecologic Cancer.

[10]  Jae-Weon Kim,et al.  Gynecologic Cancer Intergroup (GCIG) Consensus Review for Ovarian Germ Cell Tumors , 2014, International Journal of Gynecologic Cancer.

[11]  A. Gadducci,et al.  Menstrual function and childbearing potential after fertility-sparing surgery and platinum-based chemotherapy for malignant ovarian germ cell tumours , 2014, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

[12]  H. Chung,et al.  The Role of Omentectomy and Random Peritoneal Biopsies as Part of Comprehensive Surgical Staging in Apparent Early-Stage Epithelial Ovarian Cancer , 2014, Annals of Surgical Oncology.

[13]  Jaime Prat,et al.  Staging classification for cancer of the ovary, fallopian tube, and peritoneum , 2014, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[14]  N. Teng,et al.  The omentum and omentectomy in epithelial ovarian cancer: a reappraisal: part II--The role of omentectomy in the staging and treatment of apparent early stage epithelial ovarian cancer. , 2013, Gynecologic oncology.

[15]  N. Teng,et al.  The omentum and omentectomy in epithelial ovarian cancer: a reappraisal. Part I--Omental function and history of omentectomy. , 2013, Gynecologic oncology.

[16]  J. Lang,et al.  The significance of comprehensive staging surgery in malignant ovarian germ cell tumors. , 2013, Gynecologic oncology.

[17]  C. Rinker-Schaeffer,et al.  Milky spots promote ovarian cancer metastatic colonization of peritoneal adipose in experimental models. , 2013, The American journal of pathology.

[18]  Figo Guidelines.  Staging classification for cancer of the ovary, fallopian tube, and peritoneum☆ , 2013 .

[19]  H. Mizunuma,et al.  Is omentectomy mandatory in the operation for ovarian cancer? Preliminary results in a rat study. , 2012, European journal of obstetrics, gynecology, and reproductive biology.

[20]  M. Geraci,et al.  Comparative incidence patterns and trends of gonadal and extragonadal germ cell tumors in England, 1979 to 2003 , 2012, Cancer.

[21]  N. Huang,et al.  Cellular Basis of Tissue Regeneration by Omentum , 2012, PloS one.

[22]  D. Gershenson.  Current advances in the management of malignant germ cell and sex cord-stromal tumors of the ovary. , 2012, Gynecologic oncology.

[23]  H. Earl,et al.  Multidisciplinary management of malignant ovarian germ cell tumours. , 2011, Gynecologic oncology.

[24]  A. Gadducci,et al.  Outcome and Risk Factors for Recurrence in Malignant Ovarian Germ Cell Tumors: A MITO-9 Retrospective Study , 2011, International Journal of Gynecologic Cancer.

[25]  M. Schymura,et al.  Surgical staging of early stage epithelial ovarian cancer: results from the CDC-NPCR ovarian patterns of care study. , 2011, Gynecologic oncology.

[26]  W. Cliby,et al.  Random peritoneal biopsies have limited value in staging of apparent early stage epithelial ovarian cancer after thorough exploration. , 2009, Gynecologic oncology.

[27]  R. Sutcu,et al.  Effects of omentectomy on the peritoneal fibrinolytic system , 2008, Surgery Today.

[28]  C. Muller,et al.  Incidence and Survival Rates for Female Malignant Germ Cell Tumors , 2006, Obstetrics and gynecology.

[29]  S. Meijer,et al.  Insufficient ability of omental milky spots to prevent peritoneal tumor outgrowth supports omentectomy in minimal residual disease , 2006, Cancer Immunology, Immunotherapy.

[30]  W. London,et al.  Outcome and staging evaluation in malignant germ cell tumors of the ovary in children and adolescents: an intergroup study. , 2004, Journal of pediatric surgery.

[31]  A. Dirican,et al.  Influence of Omentectomy on Peritoneal Defense Mechanisms in an Experimental Model of Intra-Abdominal Infection , 2003, European Surgical Research.

[32]  N. Hacker,et al.  Conservative surgery to preserve ovarian function in patients with malignant ovarian germ cell tumors , 2000, Cancer.

[33]  S. Meijer,et al.  Effect of intraperitoneal administration of granulocyte/macrophage-colony-stimulating factor in rats on omental milky-spot composition and tumoricidal activity in vivo and in vitro , 1996, Cancer Immunology, Immunotherapy.

[34]  S. Liao,et al.  Adjuvant therapy of ovarian germ cell tumors with cisplatin, etoposide, and bleomycin: a trial of the Gynecologic Oncology Group. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[35]  D. Gershenson.  Update on malignant ovarian germ cell tumors , 1993, Cancer.

[36]  C. Stringer,et al.  Treatment of malignant germ cell tumors of the ovary with bleomycin, etoposide, and cisplatin. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.